Keywords: Teva, Third-quarter 2011 financial results

Generics giant Teva posts 3rd-qtr 2011 sales rise but net income down 13%

Article | 02 November 2011

Print This

The world’s largest generic drugs maker, Teva Pharmaceutical Industries (Nasdaq: TEVA), has reported results for the quarter ended ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in